Correction to: Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer (Naunyn-Schmiedeberg's Archives of Pharmacology, (2022), 395, 3, (315-324), 10.1007/s00210-022-02203-9)

  • He Jiang
  • , Guotai Wang
  • , Jingtao Gu
  • , Ying Xiao
  • , Pengli Wang
  • , Xin Huang
  • , Huanchen Sha
  • , Zheng Wang
  • , Qingyong Ma

Research output: Contribution to journalComment/debate

Abstract

The authors regret that Fig. 1 containing a pair of invasion photos, which is located in red frame of I position as below, should be replaced due to error. It came to attention after publication. The reason is that author mistakenly saved photos from lab’s shared computer in the final steps of data preparation. (Figure presented.) In order to meet high standard of Naunyn-Schmiedebergs Archives of Pharmacology and to be responsible for preciseness of study, I wish to perform a corrigendum of Fig. 1. The corrected Fig. 1 is provided below. This error did not impact the conclusions of the article. The authors apologize for this error. (Figure presented.).

Original languageEnglish
Pages (from-to)1591-1593
Number of pages3
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume396
Issue number7
DOIs
StatePublished - Jul 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer (Naunyn-Schmiedeberg's Archives of Pharmacology, (2022), 395, 3, (315-324), 10.1007/s00210-022-02203-9)'. Together they form a unique fingerprint.

Cite this